IL1B and non-small cell lung carcinoma: For instance, in non-small-cell lung cancer (NSCLC), IL-1β-induced epithelial–mesenchymal transition (EMT) promotes SLUG-dependent epigenetic modifications of the E-cadherin and CDH1 promoters.